SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-021453
Filing Date
2008-04-09
Accepted
2008-04-09 17:04:51
Documents
1
Period of Report
2008-04-08

Document Format Files

Seq Description Document Type Size
1 v110210_ex.html 4  
1 v110210_ex.xml 4 5771
  Complete submission text file 0001144204-08-021453.txt   7582
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address 33 HARBOUR SQUARE SUITE 202 TORONTO ONTARIO A6 M5J 2G2 4163642551
BERNSTEIN GERALD (Reporting) CIK: 0001205433 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 08748189